-
Your prediction
Arena Pharmaceuticals Inc Stock
Arena Pharmaceuticals, Inc. (Symbol ARNA) is a biopharmaceutical company based in San Diego, California that focuses on the research, development, and commercialization of novel medications. The company's primary focus is on developing small molecule drugs that target G protein-coupled receptors, which are involved in a wide range of physiological processes. Arena has a diverse pipeline of potential drug candidates in various stages of development, including treatments for pulmonary arterial hypertension, pain, autoimmune diseases, and more. The company's stock is listed on the NASDAQ exchange and is widely considered to be a high-risk/high-reward investment.
Pros and Cons of Arena Pharmaceuticals Inc in the next few years
Pros
Cons
Performance of Arena Pharmaceuticals Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Arena Pharmaceuticals Inc | - | - | - | - | - | - | - |
Ironwood Pharmaceuticals | -0.990% | -0.990% | 3.627% | -53.488% | -60.784% | -60.784% | -54.447% |
Arrowhead Pharmaceuticals Inc. | 3.930% | 3.638% | -10.043% | -28.075% | -32.724% | -65.667% | -28.048% |
Novocure Ltd | -2.190% | 1.341% | -2.218% | -6.729% | 11.173% | -85.811% | -78.086% |